These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi. Sun Y, Tan L, Yao Z, Gao L, Yang J, Zeng T. Microbiol Spectr; 2022 Feb 23; 10(1):e0200721. PubMed ID: 35019705 [Abstract] [Full Text] [Related]
4. In vitro synergistic activity of ketoconazole with valproic acid against Candida species. Krajewska-Kułak E, Niczyporuk W. Arzneimittelforschung; 1996 Sep 23; 46(9):934-6. PubMed ID: 8876946 [Abstract] [Full Text] [Related]
7. Piperazine-Modified Ketoconazole Derivatives Show Increased Activity against Fungal and Trypanosomatid Pathogens. Štěpánek O, Čmoková A, Procházková E, Grobárová V, Černý J, Slapničková M, Zíková A, Kolařík M, Baszczyňski O. ChemMedChem; 2022 Nov 04; 17(21):e202200385. PubMed ID: 36115047 [Abstract] [Full Text] [Related]
9. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans. Karasulu HY, Hilmioğlu S, Metin DY, Güneri T. Farmaco; 2004 Feb 04; 59(2):163-7. PubMed ID: 14871509 [Abstract] [Full Text] [Related]
10. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans. Mahmoud DE, Faraag AHI, Abu El-Wafa WM. World J Microbiol Biotechnol; 2021 Oct 11; 37(11):191. PubMed ID: 34632522 [Abstract] [Full Text] [Related]
11. In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Sun L, Sun S, Cheng A, Wu X, Zhang Y, Lou H. Antimicrob Agents Chemother; 2009 Apr 11; 53(4):1586-91. PubMed ID: 19171796 [Abstract] [Full Text] [Related]
14. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis. Mallié M, Montès B, Lebecq JC, Bastide JM. Mycoses; 1989 Dec 11; 32(12):631-7. PubMed ID: 2695841 [Abstract] [Full Text] [Related]
15. Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation. Hamdy R, Fayed B, Hamoda AM, Rawas-Qalaji M, Haider M, Soliman SSM. Molecules; 2020 Mar 24; 25(6):. PubMed ID: 32213931 [Abstract] [Full Text] [Related]
16. Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation. Abd Ellah NH, Abdel-Aleem JA, Abdo MN, Abou-Ghadir OF, Zahran KM, Hetta HF. Int J Pharm; 2019 Aug 15; 567():118472. PubMed ID: 31252146 [Abstract] [Full Text] [Related]
18. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients. Tantivitayakul P, Lapirattanakul J, Kaypetch R, Muadcheingka T. J Glob Antimicrob Resist; 2019 Jun 15; 17():221-226. PubMed ID: 30658200 [Abstract] [Full Text] [Related]
19. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species. Damke E, Tsuzuki JK, Cortez DA, Ferreira IC, Bertoni TA, Batista MR, Donati L, Svidzinski TI, Consolaro ME. BMC Complement Altern Med; 2011 May 04; 11():35. PubMed ID: 21542936 [Abstract] [Full Text] [Related]
20. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF. J Antimicrob Chemother; 2018 Apr 01; 73(4):891-899. PubMed ID: 29325167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]